ID

34480

Descripción

Periperal Blood Lymphocytes During Prostate RT; ODM derived from: https://clinicaltrials.gov/show/NCT01899391

Link

https://clinicaltrials.gov/show/NCT01899391

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 22/5/19 22/5/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT01899391

Eligibility Prostate Cancer NCT01899391

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
intermediate-risk prostate cancer patients (t1/t2n0m0 with either gs < 7 and psa between 10-20 ng/ml or gs 7 and psa less than 20 ng/ml).
Descripción

ID.1

Tipo de datos

boolean

planned for radical rt to the prostate with imrt planning (79gy/39fractions or 60 gy/20 fractions).
Descripción

ID.2

Tipo de datos

boolean

no contraindications to diagnostic ct scanning.
Descripción

ID.3

Tipo de datos

boolean

prostate volumes will be less than 80 cc to control the planning dose volume histogram (dvh) as much as possible in terms of rectal and bladder volumes.
Descripción

ID.4

Tipo de datos

boolean

no known dna repair disorders (e.g. family history of at, brca1/2 or li fraumeni syndrome) or contraindications to radical pelvic rt.
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
inability to provide informed consent.
Descripción

ID.6

Tipo de datos

boolean

patient having contraindications to diagnostic ct scan.
Descripción

ID.7

Tipo de datos

boolean

patients who have unobtainable data regarding previous therapy and their clinical outcome.
Descripción

ID.8

Tipo de datos

boolean

patients should not have any diagnostic x-rays or cat scans 2 weeks prior to their enrollment into the study.
Descripción

ID.9

Tipo de datos

boolean

Similar models

Eligibility Prostate Cancer NCT01899391

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
intermediate-risk prostate cancer patients (t1/t2n0m0 with either gs < 7 and psa between 10-20 ng/ml or gs 7 and psa less than 20 ng/ml).
boolean
ID.2
Item
planned for radical rt to the prostate with imrt planning (79gy/39fractions or 60 gy/20 fractions).
boolean
ID.3
Item
no contraindications to diagnostic ct scanning.
boolean
ID.4
Item
prostate volumes will be less than 80 cc to control the planning dose volume histogram (dvh) as much as possible in terms of rectal and bladder volumes.
boolean
ID.5
Item
no known dna repair disorders (e.g. family history of at, brca1/2 or li fraumeni syndrome) or contraindications to radical pelvic rt.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
inability to provide informed consent.
boolean
ID.7
Item
patient having contraindications to diagnostic ct scan.
boolean
ID.8
Item
patients who have unobtainable data regarding previous therapy and their clinical outcome.
boolean
ID.9
Item
patients should not have any diagnostic x-rays or cat scans 2 weeks prior to their enrollment into the study.
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial